BIOMAT Database Logo BIOMAT Database Logo

[Efficacy of chemo-hormonotherapy on the incidence of recurrence in resectable bladder carcinoma]. 1979

G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna

UI MeSH Term Description Entries
D008525 Medroxyprogesterone A synthetic progestational hormone used in veterinary practice as an estrus regulator. (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione,Methylhydroxyprogesterone,Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-,17 alpha-Hydroxy-6 alpha-Methylprogesterone,Adgyn Medro,17 alpha Hydroxy 6 alpha Methylprogesterone
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.
October 1994, Journal of chemotherapy (Florence, Italy),
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Management of inoperable carcinoma of the breast by curative radiotherapy and chemo-hormonotherapy.
June 2001, Onkologie,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Neoadjuvant chemo-irradiation in un-resectable carcinoma of rectum.
January 2004, Journal of Ayub Medical College, Abbottabad : JAMC,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
[Chemo-hormonotherapy and the quality of life of the cancer patient].
September 1986, Revue medicale de Liege,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
[Proposed model for evaluation of toxicity in antineoplastic chemo-hormonotherapy].
November 1978, Minerva medica,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Modulated chemo-hormonotherapy in advanced breast cancer. A pilot study.
February 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
[Hormonotherapy of carcinoma of the endometrium].
October 1986, Minerva ginecologica,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
[Current status of adjuvant chemo- and hormone therapy in resectable breast carcinoma].
October 1987, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma.
December 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
G Bernardo, and S Fantoni, and D Colloi, and Q Cuzzoni, and D Vicini, and G Robustelli Della Cuna
Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer.
June 1996, The British journal of surgery,
Copied contents to your clipboard!